$2.47T
Total marketcap
$82.1B
Total volume
BTC 50.54%     ETH 14.99%
Dominance

RIV Capital CNPOF Stock

0.07 USD {{ price }} -2.046786% {{change_pct}}%
Exchange
Other OTC
Market Cap
9.43M USD
LOW - HIGH [24H]
0.07 - 0.07 USD
VOLUME [24H]
42.68K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.33 USD

RIV Capital Price Chart

RIV Capital CNPOF Financial and Trading Overview

RIV Capital stock price 0.07 USD
Previous Close 0.09 USD
Open 0.09 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0.09 - 0.1 USD
52 Week Range 0.08 - 0.57 USD
Volume 35.71K USD
Avg. Volume 33.88K USD
Market Cap 13.83M USD
Beta (5Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) -0.33 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

CNPOF Valuation Measures

Enterprise Value 26.7M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 2.0318518
Price/Book (mrq) 0.14236312
Enterprise Value/Revenue 3.922
Enterprise Value/EBITDA -1.61

Trading Information

RIV Capital Stock Price History

Beta (5Y Monthly) N/A
52-Week Change -82.36%
S&P500 52-Week Change 20.43%
52 Week High 0.57 USD
52 Week Low 0.08 USD
50-Day Moving Average 0.09 USD
200-Day Moving Average 0.2 USD

CNPOF Share Statistics

Avg. Volume (3 month) 33.88K USD
Avg. Daily Volume (10-Days) 28.79K USD
Shares Outstanding 135.41M
Float 125.65M
Short Ratio N/A
% Held by Insiders 19.17%
% Held by Institutions 24.27%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends March 31, 2023
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End March 31, 2024

Profitability

Profit Margin 0%
Operating Margin (ttm) -265.84%
Gross Margin 35.34%
EBITDA Margin -243.58%

Management Effectiveness

Return on Assets (ttm) -3.76%
Return on Equity (ttm) -101.46%

Income Statement

Revenue (ttm) 6.81M USD
Revenue Per Share (ttm) 0.04 USD
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -16581000 USD
Net Income Avi to Common (ttm) -179259008 USD
Diluted EPS (ttm) -1.06
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 97.86M USD
Total Cash Per Share (mrq) 0.62 USD
Total Debt (mrq) 110.32M USD
Total Debt/Equity (mrq) 101.35 USD
Current Ratio (mrq) 16.389
Book Value Per Share (mrq) 0.694

Cash Flow Statement

Operating Cash Flow (ttm) -23358000 USD
Levered Free Cash Flow (ttm) -26301284 USD

Profile of RIV Capital

Country United States
State ON
City Toronto
Address 40 King Street West
ZIP M5H 3Y2
Phone 416-583-5945
Website https://www.rivcapital.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees N/A

RIV Capital Inc., formerly known as Canopy Rivers Inc., is a venture capital firm. The firm is a stage agnostic, with seed to sale, although it prefers to invest in series A to C rounds. It prefers to make investments in cannabis sector with focus on burgeoning marijuana companies and sectors like agriculture and food sciences, production, processing, pharmaceuticals and biotechnology, software and data, hardware, consumer products and accessories, wellness products, retail and distribution, and media and content. The firm also focuses on beverages, capsules and concentrates, edibles, dry flower / pre-rolls, vaporizers and hardware, pet products, and topicals. In agriculture and food sciences firm focuses in invest plant science, soil science, food science, animal science and environmental science. In production firm focuses in Indoor cultivation, greenhouse cultivation, outdoor cultivation, nursery cultivation and fermentation. In processing firm focuses in harvesting, extraction and purification, packaging, food and beverage processing and laboratory testing services. In pharmaceuticals and biotechnology firm focuses in pharmaceutical discovery and development, delivery method (ex: pill, soft gel, tincture), biosynthetic derived cannabinoids and other molecules, medical devices (ex: inhalers) and lab equipment. In consumer products and accessories firm focuses in edibles, beverages, inhalable, cosmetics and cannabis consumption accessories. In retail and distribution firm focuses in licensed brick and mortar retailers, pharmacies, online consumer marketplaces, delivery services, and others. The firm invests in opportunities globally. The firm prefers to invest in check sizes have ranged from CA$1 million ($0.71 million) to $40 million ($28.45 million), but more typical investment range is between CA$5 million ($3.6 million) to CA$10 million ($7.1 million). The firm is focused on making minority stake investments. Firm employ diverse investment structures including debt, preferred and common equity, and production-linked royalties. RIV Capital Inc. was founded on 2017 and is based in Toronto, Canada.

Q&A For RIV Capital Stock

What is a current CNPOF stock price?

RIV Capital CNPOF stock price today per share is 0.07 USD.

How to purchase RIV Capital stock?

You can buy CNPOF shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for RIV Capital?

The stock symbol or ticker of RIV Capital is CNPOF.

Which industry does the RIV Capital company belong to?

The RIV Capital industry is Drug Manufacturers-Specialty & Generic.

How many shares does RIV Capital have in circulation?

The max supply of RIV Capital shares is 140.69M.

What is RIV Capital Price to Earnings Ratio (PE Ratio)?

RIV Capital PE Ratio is now.

What was RIV Capital earnings per share over the trailing 12 months (TTM)?

RIV Capital EPS is -0.33 USD over the trailing 12 months.

Which sector does the RIV Capital company belong to?

The RIV Capital sector is Healthcare.